Frontlight ResearchEarly access
Not yet recruitingPhase 3
Glutamine Early Start in Children With SCD Younger Than Five
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 70 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Glutamine
- Standard of Care (SOC)
- Record updated
- 17 November 2026
Who can take part
- Age
- 1 year to 5 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Age from 1-5 years
- children diagnosed with SCD based on clinical picture, CBC, reticulocyte count, markers of hemolysis and hemoglobin analysis by HPLC
Who cannot take part
- Patients with clinically significant renal or liver disease
- Patients with any clinical evidence of infection
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sickle cell disease
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A study to assess the efficacy and safety of Glutamine in preventing Vaso Occlusive Crisis in pediatric population less than five years old
The 2 groups in the trial
- Patients receiving standard of careExisting treatment, for comparison
Treatment: Standard of Care (SOC)
- Patients receiving GlutamineTreatment being tested
Treatment: Glutamine and Standard of Care (SOC)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
Download the PDF
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Efficacy of Glutamine in Preventing Vaso-occlusive Crisis Among Children With Sickle Cell Disease Younger Than Five
- Criteria questions
- Built from NCT07940569, who can take part
- Record updated
- 17 November 2026